---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-099678"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2026-08-21T20:05:36+00:00"
generated_at: "2026-08-21T20:07:24.624801+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# DarioHealth President & CCO Steven Nelson departs Sept 1, 2026; consulting to 2027

## Summary
- Ceases as President & Chief Commercial Officer effective Sept 1, 2026; employment terminates Sept 30, 2026.
- Separation agreement: earned wages and health coverage through Sept 30; COBRA reimbursement of $2,600/month up to 3 months.
- Consulting agreement Oct 1, 2026–Dec 31, 2027 grants 30,000 restricted shares (vest at 1-yr anniversary or change in control); 15,000 vest immediately if terminated early.
- Outstanding unvested equity awards expire on termination; 6-month non-compete and 12-month non-solicitation apply.
- He will cooperate with transition through Dec 31, 2026.

## SEC filing metadata
- accession: 0001104659-26-099678
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2026-08-21T20:05:36+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465926099678/0001104659-26-099678-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465926099678/tm2623745d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-099678
- JSON: https://secwatch.observer/filing/0001104659-26-099678.json
- Plain text: https://secwatch.observer/filing/0001104659-26-099678.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.